This article**[CCTV News Client];
Today (January 1), the new version of the national medical insurance drug catalogue was officially implemented, which means that from today onwards, the insured people around the country will be reimbursed in accordance with the scope of drugs and ** in the new version of the catalogue when they see a doctor and buy drugs.
The total number of drugs in the new version of the medical insurance drug catalogue has increased to 3,088, including 1,698 Western medicines and 1,390 Chinese patent medicines, compared with the previous one, a total of 126 new drugs have been added in this adjustment, including 21 kinds of tumor drugs, 17 kinds of new crown and anti-infective drugs, 15 kinds of drugs for chronic diseases such as diabetes, psychiatry, rheumatism and immunity, 15 kinds of drugs for rare diseases (of which avatinib tablets are also tumor drugs), and 59 kinds of drugs in other fields.
This is the sixth consecutive year that the National Health Insurance Administration has adjusted the drug catalog, and a total of 744 drugs have been added to the national medical insurance drug catalog, and the rationality of clinical drug use has been actively improved. The National Health Insurance Administration said that this year, the average price of newly included drugs included in the medical insurance was reduced by 61 through negotiation and bidding7%, combined with negotiated price reductions and medical insurance reimbursement factors, it is expected to reduce the burden on patients by more than 40 billion yuan in the next two years.
The new version of the National Medical Insurance Drug Catalogue and the allocation of drugs negotiated by the National Medical Insurance can be queried on the official ** and related platforms of the National Health Insurance Administration.